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Abstract
Background: Cells in solid tumours are variably hypoxic and hence resistant to radiotherapy - the essential role of
oxygen in the efficiency of irradiation has been acknowledged for decades. However, the currently available
methods for performing hypoxic experiments in vitro have several limitations, such as a limited amount of parallel
experiments, incapability of keeping stable growth conditions and dependence on CO2 incubator or a hypoxia
workstation. The purpose of this study was to evaluate the usability of a novel portable system (Minihypoxy) in
performing in vitro irradiation studies under hypoxia, and present supporting biological data.
Materials and methods: This study was conducted on cancer cell cultures in vitro. The cells were cultured in
normoxic (~ 21% O2) or in hypoxic (1% O2) conditions either in conventional hypoxia workstation or in the
Minihypoxy system and irradiated at dose rate 1.28 Gy/min ± 2.9%. The control samples were sham irradiated. To
study the effects of hypoxia and irradiation on cell viability and DNA damage, western blotting, immunostainings
and clonogenic assay were used. The oxygen level, pH, evaporation rate and osmolarity of the culturing media on
cell cultures in different conditions were followed.
Results: The oxygen concentration in interest (5, 1 or 0% O2) was maintained inside the individual culturing
chambers of the Minihypoxy system also during the irradiation. The radiosensitivity of the cells cultured in
Minihypoxy chambers was declined measured as lower phosphorylation rate of H2A.X and increased clonogenic
capacity compared to controls (OER~ 3).
Conclusions: The Minihypoxy system allows continuous control of hypoxic environment in multiple wells and is
transportable. Furthermore, the system maintains the low oxygen environment inside the individual culturing
chambers during the transportation and irradiation in experiments which are typically conducted in separate facilities.
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Background
The lack of sufficient oxygen in tissues, i.e., hypoxia plays a
central role in many physiological and pathological condi-
tions. It is a major microenvironmental factor affecting cel-
lular signalling in many diseases including cancer, stroke,
atherosclerosis, inflammatory diseases such as rheumatoid
arthritis, and neurodegenerative diseases [1, 2]. Several
studies have shown that most solid tumours suffer from
insufficient oxygen supply both acutely and chronically
(reviewed in [3]). This is mainly caused by structurally and
functionally abnormal vascularization of the tumour and
limited diffusion capacity of oxygen. Hypoxia causes
genome and proteome level changes in cancer cells leading
to alterations in cell proliferation, cell cycle progression,
metabolism, and cell survival and death (reviewed in [4]).
Some of the changes restrict the tumour growth but
hypoxia causes also a strong selective pressure towards a
more aggressive tumour type.
Besides cancer progression, hypoxia also affects the
outcome of cancer treatments including chemotherapy
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and radiotherapy [5]. The effect of radiotherapy relies
partially on direct DNA damage but mainly on the oxy-
gen radicals (ROS) formed by irradiation that requires
molecular oxygen (reviewed in [6, 7]). Additionally,
hypoxia also changes the positioning of the cells in cell
cycle, which is a major factor affecting the responsive-
ness of the cancer cells to treatment including radiother-
apy [8–10]. Many of the hypoxia responsive events are
mediated by hypoxia-inducible factors (HIFs). HIFs are
transcription factors governing the expression of over
two hundred known genes involved in cell survival and
metabolism, cell cycle progression and proliferation,
motility and apoptosis (reviewed in [11]).
The conditions where in vitro studies are conducted
would ideally correspond to the conditions in vivo as au-
thentically as possible. Chemicals partially mimicking
hypoxia such as cobalt chloride (CoCl2) as well as des-
ferrioxamine (DFO) and dimethyloxalylglycine (DMOG)
that act as inhibitors of prolyl 4-hydroxylases regulating
the activity of HIFs but fail to mimic the tumour micro-
environment. Various set-ups for achieving true hypoxic
conditions in vitro have been established [12, 13]. The
conventional method to induce hypoxia is to incubate
cells in a tri-gas incubator or a hypoxia workstation.
However, this restricts the types of treatments that can
be performed in a low oxygen environment. Using work-
stations, the effect of hypoxia on radiosensitivity can
only be studied by preincubating the cells in hypoxia to
induce the adaptive system to low oxygen [14, 15].
The drawback of this method is that the cells are
reoxygenated prior to irradiation. Therefore, it does
not represent hypoxic tumour microenvironment. In
addition, reoxygenation itself induces DNA damage
[16], and thus interferes the detection of DNA dam-
age caused by reoxygenation observed in tumours
after radiotherapy [17–19].
To achieve mobility in the experiments and to expose
cells to simultaneous hypoxia and irradiation, the most
common solution is to use commercially available hyp-
oxia containers. Here the cells are placed in a sealed
container that is purged with a desired gas mix [20–25].
Similarly, sealed containers can be utilized to create
anaerobic conditions or low oxygen conditions with
oxygen scavengers [26, 27]. However, there is no inde-
pendent temperature or further O2 or CO2 control.
Therefore, the entire container with the cells inside
needs to be incubated inside a normal incubator, and
during the transportation and treatment, the
temperature drops rapidly. In addition to commercially
available products, there are also other solutions
including a hypoxic atmosphere generated in a plastic
bag [28] or in a self-made hypoxia containers [29].
Although budget-friendly, the oxygen conditions inside
these types of hypoxia containers is difficult to maintain
without feedback control [30]. Furthermore, the final
oxygen level in the culture medium depends on the ma-
terials placed inside the chamber [21, 31]. Additionally,
the hypoxia containers require high volume of expensive
ready-made gas mixtures. Most importantly, large hyp-
oxia containers exclude the use of multiple parallel
experiments.
Here we present a novel system for performing hyp-
oxia and especially hypoxic in vitro irradiation experi-
ments. The portable Minihypoxy system consists of 1–6
individual 1-well culture chambers. Each chamber is in-
dependent from others and equipped with its own gas
supply port. This enables flexible experiment planning
where several different radiation doses and time points
can be used within the same experiment. In our experi-
ments, we have used a gas mixture supplied with 1% O2
but the partial oxygen pressure is convertible down to
anoxic (< 0.1% O2) conditions. Our results show that the
Minihypoxy system is functional and easy to use. The in-
dividual chambers can be disengaged from the system at
least for 10 min without losing the hypoxic conditions
or the desired temperature inside the chamber. This
enables hypoxic in vitro irradiation experiments with




The Minihypoxy system is based on our previous studies
[32, 33]. Briefly, it is a portable platform that maintains
the desired atmosphere while transporting cells and, for
example, during microscopy or irradiation experiments.
The Minihypoxy system consists of a refillable gas cylin-
der (Catalina Cylinders, CA, USA), an ITO heater plate
and a controller (Okolab s.r.l., Italy), a custom-made
6-well flow divider and 1-well culture chambers (Mini-
hypoxy chambers) with covers and lids (Fig. 1a and b).
The refillable gas cylinder can be loaded with any de-
sired gas mixture. In this study, we used a gas mixture
of 1% O2, 5% CO2, and 94% N2 (Linde gas, Riihimäki,
Finland). Gas flow is regulated by adjusting the outlet
pressure from the cylinder. In this study, we used a flow
rate of 5 ml/min for all six supply lines (30 ml/min in
total for six-wells). The operation time of the Minihy-
poxy systems with one fully loaded gas container for six
Minihypoxy chambers is about 30 h. The gas mixture
flows through the custom-made aluminium 6-well flow
divider (SaloTeam Oy, Salo, Finland) to the Minihypoxy
chambers. The ITO heater maintains the temperature in
the desired temperature (37 °C in this study). The Mini-
hypoxy culture chambers were fabricated as described in
[32] using gas permeable polydimethylsiloxane (PDMS,
Sylgard 184, Dow Corning, USA). Each chamber was
sealed water-tightly using a glass lid (1 mm thick and
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20.5 mm in diameter) from the top. The lid prevented
evaporation and contamination inside the chamber. The
cover is made of polymer by 3D printing (Keijom Oy,
Pirkkala, Finland). The purpose of the cover is to main-
tain the desired gas environment around the PDMS cul-
ture chamber. Because of high gas permeability of
PDMS, the gas mixture diffuses through the Minihypoxy
chamber to the cells. The weight of the Minihypoxy
system is 3.3 kg.
Measuring oxygen concentration inside the Minihypoxy
chamber
The oxygen concentrations inside the culture chamber
were measured utilizing an in-house developed optical
Fig. 1 Structure and functionality of the Minihypoxy system. a A schematic diagram of the detailed structure of the system. The system consists
of a refillable gas cylinder, a 6-well flow divider, a heater and a temperature controller, and six 1-well culture chambers (Minihypoxy chambers)
made from polydimethylsiloxane (PDMS). b A picture of the Minihypoxy system, the 6-well flow divider and the Minihypoxy culture chamber on
a glass substrate (1) with a lid (2) and a cover (3). c Dynamic response in the Minihypoxy culture chamber to descending and ascending oxygen
level. The responses were tested on three different oxygen concentrations: 5% O2 (black line), 1% O2 (red line) and 0% O2 (blue line). Ascending
oxygen level was reached by disconnecting the gas supply. The 1% O2 curve shows also the response to three short gas supply cut-offs
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oxygen measurement setup [34]. Briefly, the Minihy-
poxy culture chamber was placed on top of a 0.5 mm
thick glass substrate which contained oxygen sensitive
fluorescent dyes. The chamber was filled with deion-
ized water (1 ml), sealed using the lid and the cover,
and placed on top of the ITO heater that maintained
temperature at 37 °C. Optical reading of the fluores-
cent dyes in the Minihypoxy chamber was performed,
through the ITO and glass substrates. The oxygen
concentrations were measured using gas mixtures
containing 0, 1 and 5% oxygen supplied from the pre-
filled gas cylinders. We also determined the dynamics
of the oxygen concentration change in the Minihy-
poxy system when the gas supply was disconnected
for a 5-min time period to mimic the irradiation
treatment. All experiments were done with the flow
rate of 5 ml/min.
pH, evaporation and osmolarity of cell culture medium
The pH was measured as an end-point measurement util-
izing a microFET pH meter (SI600with microFET sensor,
Sentron, The Netherlands). Evaporation was estimated by
determining the mass change during the experiment by
weighting the wells before and after the experiment.
OsmoMat 030 osmometer (GonoTec GmbH, Germany)
was used for measuring the osmolarity.
Cell culture
HeLa cervical cancer cell line and LNCaP prostate can-
cer cell line were obtained from ATCC (Rockville, MD,
USA). UT-SCC74 primary cell line derived from human
head and neck squamous cell carcinoma (HNSCC) was
kindly provided by Prof Reidar Grénman. HeLa cells
were cultured in Dulbecco’s Modified Eagle Medium
(DMEM, Sigma-Aldrich), UT-SCC74 cells in Minimun
Essential Medium Eagle with alpha modification
(α-MEM, Gibco) and LNCaP cells in Roswell Park Me-
morial Institute medium (RPMI-1640, Gibco). All media
were supplied with 10% fetal calf serum (FCS),
L-glutamine and antibiotics (penicillin and strepto-
mycin). Cells were cultured in 37 °C in air/5% CO2 and
tested negative for mycoplasma once a month. The refer-
ence cells for the Minihypoxy system were cultured in 1%
oxygen and 5% CO2 in the hypoxia workstation (Invivo2
400, Ruskinn Technology). The reference cells were plated
on Minihypoxy culture chambers attached to glass sub-
strate. Chambers were covered with the glass lid and kept
on Petri dishes during incubation and for convenience in
handling. For live cell imaging the cells were transfected
with EGFP expression vector. Transfection reagent Lipo-
fectamine 3000 (Invitrogen) was used according to manu-
facturer’s specifications. The images were obtained with
LSM780 microscope (Carl Zeiss, Oberkochen, Germany).
Protein detection and antibodies
For protein detection, western blotting and immuno-
fluorescence staining were used. For protein expression
analysis, cells were harvested in SDS-Triton lysis buffer.
Protein concentration was measured using Bio-Rad DC
Protein assay and protein detection using Pierce ECL
Western blotting substrate (Thermo Scientific). Anti-
bodies used were: HIF-1α (610959, BD Transduction La-
boratories), phospho-H2A.X (Ser139) (2577, Cell
Signaling), H2A.X (2595, Cell Signaling), GAPDH
(5G4-6C5, HyTest), and β-actin (Ac-74, Sigma-Aldrich).
For immunofluorescence staining, cells were fixed with
ice cold methanol. The DNA double strand breaks were
visualized using antibody against phosphorylated H2A.X
(γH2A.X) (2577, Cell Signaling). The nuclei were stained
using Hoechst 33342 (Invitrogen). Cells were imaged
with Olympus BX60 (40X). The intensity of the phos-
phorylated H2A.X staining per cell (minimum 4 optical
fields yielding minimum 150 cells per condition) was
measured using ImageJ software (NIH, USA). Experi-
ments were done as parallel treatments and each experi-
ment was repeated at least three times.
Irradiation
Irradiations were performed using the Faxitron Multirad
350 (Faxitron Bioptics, LLC) located in Turku PET
Centre at the Turku University Hospital and University
of Turku, Finland. The voltage was set to 250 kV with a
current of 14 mA (dose rate 1.28 Gy/min ± 2.9% at
50 cm distance from the radiation source). The X-ray
beam was hardened with a 0.3 mm copper filter. Cells
were exposed to 2 or 6 Gy doses. The control samples
(0 Gy) were sham irradiated.
The cells were transported to the irradiator in
protected boxes (normoxic and hypoxic preconditioned
references) or in the Minihypoxy system. This
minimized the possible stress caused by temperature
variations. Radiation exposures were conducted at room
temperature. The Minihypoxy chambers were discon-
nected from the flow divider and placed in the irradiator.
After the irradiation, the Minihypoxy chambers were
connected back to the Minihypoxy system. Reference
cultures were placed into a standard incubator for 1 h
before the sample collection.
Clonogenic assay
To study the radiosensitivity of the cells, clonogenicity
was determined. First, to find an optimal cell amount for
the assay, the plating efficiency (PE) was determined.
Briefly, cells were plated at different densities on 6-well
plates (100–1000 cells/ml) and cultured for seven days
at standard cell culturing conditions (+ 37 °C in air/5%
CO2). The colonies were stained using crystal violet and
colonies (> 50 cells) were counted using Image J. The PE
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was calculated by dividing the average colony count with
cells plated (PE = no of colonies formed/no of cells
seeded * 100). For the actual radiosensitivity experiment,
density of 750 cells per well was selected.
The cells were seeded into the Minihypoxy chambers
and incubated in 1% O2 (Minihypoxy and precondi-
tioned reference in the hypoxia workstation) or 21%
oxygen (normoxic reference in a standard incubator) for
24 h. The cells were irradiated at doses of 0, 2 or
6 Gy and immediately re-plated on a 6 well plate at
375 cells/ml, 2 ml per well for clonogenic assay and
cultured in standard cell culturing conditions for
seven days. Staining and quantification was performed
as described above. The survival fraction was calcu-
lated using formula SF = no of colonies formed after
treatment/(no of cells seeded * PE) as described pre-
viously [35].
Results
Partial oxygen pressure (pO2) inside the Minihypoxy
culture chamber
The Minihypoxy system consists of a refillable gas cylin-
der, a heat plate and a controller, a custom-made 6-well
flow divider and 1-well culture chambers (Minihypoxy
chambers) (Fig. 1a and b). A gas mixture flows through
the 6-well flow divider to the Minihypoxy chambers.
The heat plate maintains the temperature in the desired
temperature (37 °C in this study). The Minihypoxy cul-
ture chambers were sealed using glass lids and the whole
chamber with the lid is covered by a polymer-made
cover. A more detailed description of the system is
provided in materials and methods.
To demonstrate the dynamic response of the Mini-
hypoxy system to changes in oxygen supply, we
followed the oxygen concentration at the bottom of
the Minihypoxy culture chamber during the descend-
ing and ascending oxygen step response and during
the gas supply cut-offs. As shown in Fig. 1c, the oxy-
gen concentration reached the set point relatively fast.
The time constants for the descending oxygen step
responses from ambient oxygen level to the target
concentration values of 5, 1 and 0% were 21 min,
21 min and 29 min, respectively. The oxygen concen-
tration remained at the same level during the experi-
ment and was maintained as long as the gas supply
was connected. During the 5 min of gas supply
cut-off, the oxygen concentration rose approximately
0.6 percentage points but returned to the set point
after 1 h. When the Minihypoxy culture chamber was
entirely disconnected from the gas supply, the time
constants of the ascending oxygen concentration from
5, 1 and 0% to the ambient oxygen level was 52 min,
46 min and 56 min respectively.
pH, evaporation and osmolarity measurements
To show that the Minihypoxy culture chamber sealed
with a lid and a cover maintains desired cell culturing
conditions also during the irradiation treatment, we
plated HeLa cells in the Minihypoxy culture chambers
and incubated them either in the Minihypoxy system, in
a hypoxia workstation (Invivo2, Ruskinn Technology), or
a standard CO2 incubator. The chambers were irradi-
ated, and culture media was collected to measure the
pH, evaporation and osmolarity of the culturing media
after irradiation.
The measurements show that the evaporation was
slightly smaller in the Minihypoxy system than inside
the hypoxia workstation or in the incubator (Table 1).
No change was observed in the osmolarity between
the different culturing conditions. The pH increased
at a relatively high level in cultures incubated in the
hypoxia workstation or in the incubator, while the pH
measured from media of the Minihypoxy system
remained significantly lower (7.18 vs. 7.51 and 7.65).
This is probably due to the continuous gas supply
and the regulated constant temperature throughout
incubation in the Minihypoxy system, while the
chambers from hypoxia workstation and incubator are
lacking a steady CO2 supply to buffer the media dur-
ing irradiation.
Hypoxia is generated and maintained inside the
Minihypoxy chamber for a prolonged time
In addition to measuring the partial oxygen pressure
(pO2) inside the Minihypoxy chamber, we determined
biological effects on cells cultured in a Minihypoxy
chamber by using hypoxia-inducible factor 1 alpha
(HIF-1α) as a marker protein since it serves as a sensi-
tive indicator for hypoxia. HIF-1α is induced by hypoxia
and is rapidly degraded in response to increased oxygen
supply (> 5% O2) [36–39]. To ensure the effective
HIF-1α induction in the Minihypoxy chambers supplied
with 1% O2, HeLa and UT-SCC74 cells were cultured in
the Minihypoxy chamber for 24 h. Both cell lines
showed a marked induction of HIF-1α level (Fig. 2a).
The magnitude of the induction was in line with the
level of HIF-1α determined from cells cultured in the
hypoxia workstation in 1% O2 for 24 h.
In in vitro radiotherapy studies, the cells are discon-
nected from the Minihypoxy flow divider and placed
into the irradiator for approximately 5 min depending
on the radiation dose. To study how long the Minihy-
poxy chambers maintain the hypoxic microenvironment
inside the chamber without the gas flow, we performed
an experiment where the chambers were disconnected
from the Minihypoxy flow divider. After 24-h culturing,
samples were collected at four time points (5, 10, 20,
and 30 min) after cut-off of the gas flow (Fig. 2b). The
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reference samples were cultured in hypoxia workstation
(1% O2) for 24 h and then transported to a standard in-
cubator with ~ 21% oxygen. The level of HIF-1α was sig-
nificantly higher after 5, 10 and 20 min of removing gas
flow in cells cultured in the Minihypoxy chamber as
compared to reoxygenated reference samples (Fig. 2b).
Together with the measurements showing the changes
in the partial oxygen pressure inside the chamber
(Fig. 1c), this indicates that the Minihypoxy chamber
sealed with the lid and the cover maintains hypoxia
up to 20 min without the gas flow.
Enhancement of cellular radiation resistance under
hypoxia in the Minihypoxy chambers
To test the Minihypoxy system for simultaneous hypoxia
and irradiation, we determined the sensitivity of cultured
cells to radiotherapy in two oxygen conditions (1 and
21%). The experiments included determining the level of
DNA damage and cell growth studies (work flow pre-
sented in Fig. 3). Several previous studies have demon-
strated that hypoxia causes resistance to radiation and
thus shows less DNA damage as measured by serine
phosphorylation (Ser139) of H2A.X histone (γH2A.X),
which is commonly used as an indicator of double
strand DNA breakage [10, 40]. The cells were plated on
the Minihypoxy chambers and cultured in 1% O2 for
24 h prior to irradiation. The reference samples were
cultured in 21% O2 or in the hypoxia workstation in 1%
O2 for 24 h (hypoxic preconditioning). The cells were
irradiated at single doses of 0, 2 and 6 Gy, and samples
for immunostaining and western blot analysis were col-
lected one hour after irradiation (Fig. 3). As expected,
immunostaining revealed a dose-dependent increase in
the intensity of γH2A.X on HeLa cell nuclei 1 h after
Table 1 Evaporation, pH and osmolarity measured from the 1-well culture chambers on glass substrate in the Minihypoxy system,
the hypoxia workstation (hypoxia WS) and the standard incubator (n = 6)
Evaporation [ul] Evaporation [ul/h] pH Osmolarity [mOsm]
Minihypoxy system (n = 6) mean (std) 59 (14) 2.46 (0.57) 7.18 (0.06) 0.309 (0.004)
1-well in hypoxia WS (n = 6) mean (std) 94 (46) 3.90 (1.91) 7.51 (0.09) 0.306 (0.002)
1-well in incubator (n = 6) mean (std) 69 (40) 2.89 (1.67) 7.65 (0.02) 0.297 (0.002)
Fresh Medium (n = 6) mean (std) - - 7.38 (0.01) 0.298 (0.001)
A
B
Fig. 2 Hypoxic conditions are maintained in Minihypoxy chambers. a Hypoxia-inducible factor HIF-1α is equally induced in Minihypoxy system
(MH) and in hypoxia workstation (HW) in 1% O2 (HOX). The hypoxic response is shown with two carcinoma cell lines (HeLa, UT-SCC74). b The
Minihypoxy chambers (MH) were disconnected from the gas flow (no flow) and the level of HIF-1α was followed for 30 min. The control cells
were cultured in hypoxia workstation (HW) for 24 h and then transferred to normal cell incubator with 21% O2 (REOX). The samples were
collected accordingly
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irradiation under normoxia and hypoxic precondition-
ing. The increase in γH2A.X level was irradiation
dose-dependent and did not differ between normoxic
and preconditioned samples (HW) (Fig. 4a and b). In
striking contrast, the response to irradiation was strongly
diminished in the Minihypoxy chamber under 1% O2.
To reach the same treatment response in a hypoxic
Minihypoxy chamber as in 21% O2 or preconditioned
conditions, the estimated value of radiation dose would
need to be approximately three times higher (oxygen
enhancement ratio, OER~ 3). The estimation is based on
the comparison of the γH2A.X levels in different condi-
tions (Fig. 4b). A similar response was seen in western
blot analysis of both HeLa and UT-SCC74 cells. A clear
radiation dose-dependent increase in the level of
phosphorylated H2A.X seen in normoxic and hypoxia
preconditioned (HW) samples was strongly attenuated
in hypoxic Minihypoxy chamber (Fig. 4c).
Finally, we determined the clonogenic capacity of the
irradiated cells. The cells were irradiated as previously
described and plated for clonogenic assay immediately
after irradiation (Fig. 3). The clonogenic capacity of the
cells decreased rapidly in response to irradiation (Fig.
4d). However, the cells irradiated in the Minihypoxy
chambers retained some of their clonogenicity even after
6 Gy dosage, whereas the reference cells grown under
normoxia (21% O2) or preconditioned in the hypoxia
workstation (HW) lost their clonogenic potential com-
pletely (Fig. 4d). The effect was even more prominent in
primary human head and neck carcinoma UT-SCC74
cells (Fig. 4d). Taken together, the data indicate that the
Minihypoxy system can mimic the hypoxic microenvir-
onment and maintains hypoxia for prolonged time also
when transported and placed inside an irradiator.
Discussion
Hypoxia is one of the major microenvironmental factors
affecting carcinogenesis and cancer progression and is
characteristic for many pathologies such as inflamma-
tion, inflammatory diseases as well as stem cell growth.
Moreover, some normal tissues can be considered as
permanently hypoxic as the partial oxygen pressure is
constantly lower than 5%. Yet, most of the in vitro re-
search on cell cultures is still conducted under partial
oxygen pressure up to 21%. There is an obvious need for
cost-effective and easy-to-use application for a device
with adjustable oxygen concentration. Ideally, all labora-
tories especially those working on the research fields of
cancer, stem cells and inflammation, should have access
to the use of a hypoxia incubator.
Here we present a novel device for conducting in vitro
experiments in hypoxia. Our results show that experi-
ments in the Minihypoxy system are reproducible and
reliable, and results are comparable to studies performed
in a hypoxia workstation. Furthermore, the Minihypoxy
system maintains hypoxia also when transported to an-
other location as well as when used inside an irradiator.
Our results show that performing radiation experi-
ments in the Minihypoxy system markedly reduces
the radiosensitivity of carcinoma cells determined as
reduced DNA damage and attenuated loss of clono-
genic capacity, thus presenting its utility in in vitro
radiosensitivity measurements.
There are several advantages of the Minihypoxy sys-
tem over conventional hypoxia workstations or hypoxia
chambers. First, media in the Minihypoxy culture cham-
ber reaches 1% oxygen concentration within 2 h, which
is relatively fast as compared to media placed into a hyp-
oxia workstation where it may take up to 24 h for media
to reach the set point [41]. The Minihypoxy chambers
are made of silicone elastomer which is gas permeable
material and therefore enhances the gas exchange inside
the chamber. Second, in the Minihypoxy system, the
cells are steadily kept on a heat plate, which eliminates
the stress effects caused by the temperature changes.
Even small temperature changes might affect
Fig. 3 Work flow chart on in vitro irradiation experiments





Fig. 4 (See legend on next page.)
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significantly the behaviour of cells [42, 43]. Third, the
pH changes in the Minihypoxy system are minimized
compared to other hypoxia systems as the constant CO2
supply maintains the buffering capacity of the media.
Even inside a standard incubator, the conditions may
vary if the incubator is heavily used. In addition, the
closed structure of the Minihypoxy culture chamber de-
creases the evaporation and prevents the concentration
of the culture media. Evaporation increases the osmolar-
ity of the cell culture media and has a negative effect on
cells [31, 44]. In other words, the optimal composition
of the culture media can be maintained in the Minihy-
poxy system. Fourth, the Minihypoxy system also en-
ables live cell imaging under low oxygen conditions as
the chambers are designed with undisrupted optical path
(Additional file 1: Figure S1). Everyday monitoring of the
cells while in culture can be performed with the adjacent
heat plate. Therefore, the cells can also be observed and
imaged during the long-term hypoxia culturing.
Moreover, high resolution live cell imaging of individual
Minihypoxy chambers requires heated microscope
chamber to keep the temperature stable during a
long-term imaging experiment. Most importantly, the
Minihypoxy system is transportable and allows experi-
mental planning with several different independent ir-
radiation treatments and time points at the same time.
The sample collection procedure is similar in hypoxia
containers and Minihypoxy culture chambers as opening
of the container or the chamber exposes the cells to a
short period of reoxygenation stress. A benefit of the
Minihypoxy chambers compared to the hypoxia con-
tainers is that the Minihypoxy chambers can be handled
one chamber at a time while the conditions in the other
chambers are not affected. We found no difference in
the level of the marker protein HIF-1α between the
samples collected using non-preconditioned washing
buffer versus samples where preconditioned buffer was
used or which were collected inside the hypoxia work-
station (Additional file 2: Figure S2). However, as many
experimental setups would benefit from a perfusion
system, this need has been taken under consideration
when developing the next generation Minihypoxy cham-
bers. Taken together, the Minihypoxy system offers many
benefits over current methodologies for creating low oxy-
gen atmosphere for cell culture experiments in a compact
device. It also provides benefits compared to other
hypoxia solutions in regards its mobility and capability of
maintaining optimal cell growth conditions during
transportation.
Conclusions
The Minihypoxy system provides a transportable
easy-to-use platform for controlling oxygen concentra-
tion in in vitro cell cultures. In addition to the oxygen
level, the Minihypoxy system also maintains the
temperature and pH of the culture constant. Here we
present the utility of the Minihypoxy system in in vitro
irradiation experiments on carcinoma cell cultures under
reduced oxygen level. Besides simultaneous hypoxia and
irradiation the transportability of the system enables
other experimental designs performed under hypoxia.
Additional files
Additional file 1: Figure S1. Live cell images of EGFP expressing
prostate cancer cell line LNCaP cells. The images were obtained using
10× and 63× magnifications. (PDF 1137 kb)
Additional file 2: Figure S2. The samples can be collected without
performing hypoxic preconditioning on the washing buffer. The cells
were washed twice before collecting using either PBS stored in normal
21% oxygen concentration (N) or preconditioned for 24 h in 1% oxygen
concentration (pre). As a control there is a sample which is collected
inside the hypoxia incubator using preconditioned washing buffer (H).
(PDF 207 kb)
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